Navigation Links
Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006
Date:3/18/2008

DENVER, March 18 /PRNewswire-FirstCall/ -- Birner Dental Management Services, Inc. (Nasdaq: BDMS), operators of PERFECT TEETH(R) dental practices, announced results for the year ended December 31, 2007. Total dental group practice revenue increased $2.2 million, or 3.9%, to $59.4 million. Net revenue increased $1.4 million, or 3.6%, to $40.8 million. The Company's earnings before interest, taxes, depreciation, amortization and non-cash expense associated with stock-based compensation ("Adjusted EBITDA") increased $712,000, or 10.0%, to $7.8 million from $7.1 million for the year ended December 31, 2006.

Net income for the year ended December 31, 2007 increased $114,000, or 4.9% to $2.4 million. Earnings per share increased 14.7% to $1.08 for the year ended December 31, 2007 compared to $.94 for the year ended December 31, 2006.

For the quarter ended December 31, 2007, total dental group practice revenue increased $116,000, or .8%, to $13.8 million. Net revenue increased $96,000, or 1.0%, to $9.5 million. The Company's Adjusted EBITDA increased $30,000, or 1.8%, to $1.7 million for the quarter ended December 31, 2007 compared to $1.6 million for the quarter ended December 31, 2006.

Net income for the quarter ended December 31, 2007 increased $43,000, or 11.8% to $408,000. Earnings per share increased 22.3% to $.19 for the quarter ended December 31, 2007 compared to $.15 for the quarter ended December 31, 2006.

During 2007, the Company purchased 196,791 shares of its Common Stock for approximately $4.1 million and paid out just over $1.2 million in dividends to its shareholders while reducing debt outstanding by $1.7 million. In January 2008, the Company signed a lease for a de novo office in Longmont, Colorado,
'/>"/>

SOURCE Birner Dental Management Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Year End and Fourth Quarter 2007 Results
2. Birner Dental Management Services, Inc. Declares $.17 Quarterly Dividend
3. Delta Dental of Illinois Introduces Smile Smart For Your Health
4. Toms of Maine Tooth Floss Earns American Dental Associations Seal of Acceptance
5. Most comprehensive study of mercury in dental fillings begins
6. Guardians Dental Network Experiences Double-Digit Growth
7. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
8. Ohio Dental Association Installs New President and Officers
9. Delta Dental Plans Association Forms National Scientific Advisory Committee
10. Dental Researchers Participate in Global Awareness Initiative
11. Incidental findings found when radiologists take a broader look at renal MRA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...PRNewswire/ -- An exciting treatment gaining accep...latelet-rich plasma therapy (PRP), is showing stro...lant procedures, according to a prominent dental r...ntology . ,, James Rutkowski, DMD, PhD, repor... American Academy of Implant Dentistry that platel...
(Date:12/3/2009)...es rzteblatt International contains the first sci...the novel influenza A virus (H1N1/09) in the Germa...ic. Ralf Winzer and his coauthors from the Dsseldo...ata from a large clinical cohort of infected perso...770-6). Their medical-scientific article is accomp...
(Date:12/3/2009)... Deaths a day is still too many - stalled momentum... Atlanta, GA, Geneva, New York, NY a...Measles Initiative announced today that measles de...from an estimated 733 000 in 2000 to 164 000 in 20... resurgence in measles deaths if vaccination effor...
(Date:12/3/2009)...ra Pharma will be conducting a webinar on December...-counter and prescription treatments for chronic p... Plantation, FL (Vocus) December 3, 2009 -- ...company that is developing treatments for Adrenomy...S), has announced today that it will be hosting an...
(Date:12/3/2009)...f., Dec. 3 Osseon Therapeutics ann...vable bone cement delivery needle) and Osseoflex D...percutaneous vertebral augmentation received Canad... marketing and clinical use in Canada. ,, Canad... FDA approval in the United States, and allows for...
Breaking Medicine News(10 mins):Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3Health News:Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada 2
...rn to mothers who have low levels of foliate// in ...tudy. Folate is essential for fetal growth a... helping produce and maintain new cells. It is a B...und of folate, before conceiving and during the ea...
...ion for upgrading a medical college in Orissa.// ...allavbhai Patel Postgraduate Institute of Paediatr... and effectively contribute towards dispensation o...rsday by Japanese ambassador Yasukuni Enoki and Vi...
...th unhealthy foods could be used to treat// obesit...ersity of California, Irvine, and her colleagues c...eating strawberry ice cream as a child. She ...at suggested they had had an unpleasant experience...
...ip called Genotyper that can identify the genetic ... the doctors to treat patients effectively. D...n, the Genotyper is on its way to become fully por...fying the flu type is similar to genetic fingerpri...
...arean were less likely to conceive again //than th...new British study. Researchers led by Siladit...tain, followed women who had their first single ch...of mothers undergoing caesarean went on to have an...
...pes for a new drug to treat women with //low sexua...FDA) wants more studies to be done on the Intrinsa...ut what long-term side effects the drug may induce...ng with low desire. Though experts say femal...
Other Medicine News:Health News:Vitamin Supplements During Pregnancy to Boost Fetal Development 2Health News:Unpleasant Memory of Food could Be Used to Treat Obesity 2Health News:New Tools To Identify Flu Strains 2Health News:FDA Diminish Hopes On ‘Female Viagra 2Health News:FDA Diminish Hopes On ‘Female Viagra 3
(Date:12/3/2009)... HELSINKI, December 3 After two...ccess in their field, Lightlake Therapeutics, expe...lecting and gene testing,subjects for a trial of a...,World Health Organisation has described as a glob..., A Phase II trial for the everyday treatment ...
(Date:12/2/2009)...YORK, Dec. 2 Reportlinker.com anno...le in its catalogue: ,, Cardiac Pacemakers - ...linker.com/p0164335/Cardiac-Pacemakers---A-World-M...itute a major segment in a rapidly expanding cardi...cemakers market is characterized by relatively mat...
(Date:12/2/2009)...O, Calif., Dec. 2 Varian... 25, 2009, Varian, Inc. filed with the U.S. Securi...Form 10-K for the fiscal year ended October 2, 200... Company,s web site at www.varianinc.com, by click..."10-K" in the table shown. Stockholders may recei...
Breaking Medicine Technology:Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 2Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 3Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 6Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 7Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 8Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 9Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 10Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care 52780 1Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care 52780 2Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care 52780 3Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care 52780 4Olympus Managed Health Care Receives Third Party Administrative License in State of Florida 52776 1Digitas Health Expands Adding Two Key Locations 13208 1Digitas Health Expands Adding Two Key Locations 13208 2Digitas Health Expands Adding Two Key Locations 13208 3Digitas Health Expands Adding Two Key Locations 13208 4
... Surface Treatment Maximizes,Endothelialization; R...Term,Dual Antiplatelet Therapy, WASHINGTON, Oct. ...Devices and Futuristic Therapies" session during t...eutics (TCT) scientific,symposium, sponsored by th...-month follow-up data from the ATLANTA Trial. The ...
...Cancer Populations Facilitates ...3 Rubicon Genomics, Inc. today,announced an agree...r The,Cancer Atlas Genome Project., Rubicon Genom...genomic,DNA from 3,000 tissue and blood samples fr...le Genome Amplification technology was judged best...
Other Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3
PVA, The Personal Vision Assistant
...elco general purpose incubators designed to provid...equired for the most demanding incubation applicat...cubators feature push-button temperature setpoint ...ilt-in over-temperature protection. Equally import...
...ecision Economy Incubators available in five diffe...on; capacities of 1.4 cu. Ft. (39 liters), 2.5 cu....ually important, Precision Economy Incubators comb...ature sensitivity, stability, and uniformity. As a...
40D Large
Medicine Products: